Generic and Biosimilar Drugs

In this episode, Jeremy Schmerer and Ryan LaRanger discuss generic and biosimilar drugs in the context of what they are, how they come to exist, patents, and future opportunities.

You can listen to all Truncated Thoughts episodes here, and also at Apple, Spotify, and Stitcher.

If you have any questions or would like to know if we can help your business with its innovation challenges, please leave your info here or contact Jeremy Schmerer, Healthcare & Life Sciences Lead, directly at jschmerer@prescouter.com.

I’m a PhD candidate or early career researcher

I have substantial applied expertise in a domain

I’m interested in employment with PreScouter

Generic and Biosimilar Drugs

If you have any questions or would like to know if we can help your business with its innovation challenges, please leave your info here or contact Jeremy Schmerer, Healthcare & Life Sciences Lead, directly at jschmerer@prescouter.com.

Never miss an insight

I’m a PhD candidate or early career researcher

I have substantial applied expertise in a domain

I’m interested in employment with PreScouter

If you have any questions or would like to know if we can help your business with its innovation challenges, please leave your info here or contact Jeremy Schmerer, Healthcare & Life Sciences Lead, directly at jschmerer@prescouter.com.

Never miss an insight

The ultimate prompt cheat book for R&D

Analyzing manufacturing supply chain synergies for entrance into a new market category

Can AI models like ChatGPT truly think and innovate?

EV buyers are brand-agnostic: What this means for automakers

Most Popular

SearchGPT vs Google: Is AI-powered search the future?

Smart shoes: Innovations revolutionizing the future of footwear

EV buyers are brand-agnostic: What this means for automakers

The Spiral Pump: Pumping Water Without Electricity

Can AI models like ChatGPT truly think and innovate?

Never miss an insight